"We are responsible for developing clinical and commercial manufacturing processes for therapeutic proteins."
We are responsible for developing clinical and commercial manufacturing processes for therapeutic recombinant biomolecules using Chinese Hamster Ovary (CHO) and E. coli cells. We also develop & evaluate new bioprocess technologies both internally and through industry and academic collaborations to improve our manufacturing processes. Our laboratories and pilot plants are housed within the Cell Culture and Bioprocess Operations department as part of the Pharma Technical Development (PTD) organization, which serves as the bridge between research & manufacturing. Our scale of operations ranges from a few mL for research-supply materials up to 1,000L for pilot-scale production. Our operations additionally encompass the pilot-scale facilities and staff to purify & formulate biomolecules into drug substance (DS) and drug product (DP).
Additional activities in our laboratories include but are not limited to:
Biotechnol Bioeng. 2010 Jun 29.